Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Global vaccination recommendations and thimerosal.

Orenstein WA, Paulson JA, Brady MT, Cooper LZ, Seib K.

Pediatrics. 2013 Jan;131(1):149-51. doi: 10.1542/peds.2012-1760. Epub 2012 Dec 17. No abstract available.

2.

Ban on thimerosal in draft treaty on mercury: why the AAP's position in 2012 is so important.

Cooper LZ, Katz SL.

Pediatrics. 2013 Jan;131(1):152-3. doi: 10.1542/peds.2012-1823. Epub 2012 Dec 17. Review. No abstract available.

4.

CGIAR statement on UN treaty.

Swaminathan MS.

Nat Biotechnol. 2002 Jun;20(6):547. No abstract available.

PMID:
12042848
6.

Thimerosal, micromercurialism and chronic fatigue syndrome.

Miller R.

Med Hypotheses. 2005;64(5):1063-4. No abstract available.

PMID:
15780514
7.

Elimination of thimerosal from vaccines set as goal.

Miller JL.

Am J Health Syst Pharm. 1999 Aug 15;56(16):1589, 1593. No abstract available.

PMID:
10459378
8.

Legal pathways for cross-border research: building a legal platform for biomedical academia.

Bovenberg JA.

Eur J Hum Genet. 2007 May;15(5):522-4. Epub 2007 Feb 28.

9.

An assessment of thimerosal use in childhood vaccines.

Ball LK, Ball R, Pratt RD.

Pediatrics. 2001 May;107(5):1147-54. Review.

PMID:
11331700
10.

Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders.

Bigham M, Copes R, Srour L.

Can Commun Dis Rep. 2002 May 1;28(9):69-80. Review. English, French. No abstract available.

11.

Minimum eliciting patch test concentration of thimerosal.

Lisi P, Perno P, Ottaviani M, Morelli P.

Contact Dermatitis. 1991 Jan;24(1):22-6.

PMID:
2044366
12.

[Mercury-induced hypersensitivity rare after subcutaneous injection of vaccines].

Taranger J.

Lakartidningen. 1990 Apr 18;87(16):1345. Swedish. No abstract available.

PMID:
2329881
13.

New structural insights.

Gross M.

Curr Biol. 2009 Aug 25;19(16):R669-70. No abstract available.

14.

Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants.

Stajich GV, Lopez GP, Harry SW, Sexson WR.

J Pediatr. 2000 May;136(5):679-81.

PMID:
10802503
15.

Mercury as a contact allergen.

Wekkeli M, Hippmann G, Rosenkranz AR, Jarisch R, Götz M.

Contact Dermatitis. 1990 May;22(5):295-6. No abstract available.

PMID:
2383989
16.

The stubborn facts of vaccine safety.

Humiston SG.

Pediatr Ann. 2001 Jul;30(7):385-90. No abstract available.

PMID:
11469169
17.

IOM report: no link between vaccines and autism.

Meadows M.

FDA Consum. 2004 Sep-Oct;38(5):18-9. No abstract available.

18.

Thimerosal: updated statement. An Advisory Committee Statement (ACS).

National Advisory Committee on Immunization (NACI).

Can Commun Dis Rep. 2007 Jul 1;33(ACS-6):1-13. English, French. No abstract available.

19.

Principal component analysis and discrimination of variables associated with pre- and post-natal exposure to mercury.

Marques RC, Bernardi JV, Dórea JG, Bastos WR, Malm O.

Int J Hyg Environ Health. 2008 Oct;211(5-6):606-14. Epub 2007 Dec 21.

PMID:
18160342
20.

Supplemental Content

Support Center